PNEUMONIX AWARDED MARYLAND INDUSTRIAL PARTNERSHIPS PROGRAM PHASE I GRANT
Feb 1, 2019
1 min read
top of page
Recent Posts
See AllPneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.
PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...
PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...
bottom of page
Comments